Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Particle Sciences Expands cGMP Capabilities | Contract Pharma

What are you searching for?

Sign in
Breaking News

Particle Sciences Expands cGMP Capabilities

Adds coating for preparing polymer film-based drugs

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Particle Sciences has added new coating capabilities for preparing polymer film-based drug products from liquid formulations, under cGMPs. The company focuses on advanced drug delivery solutions and is FDA registered and licensed for all schedules of controlled substances.
 
Garry Gwozdz, director of Formulation Services, said, “Particle Sciences’ purpose is to provide our clients with the most efficient drug product. Increasingly, we are seeing a demand for thin film-based products, particularly with respect to transdermal drug-eluting patch products, and rapidly-dissolving strips. While we have been working in this area for some time, the acquisition of semi-automated coating equipment will allow us to screen more formulation approaches, and get our clients into the clinic faster with a commercially representative film-based product.”
 
Mr. Gwozdz added, “Particle Sciences already had cGMP hot-melt film extrusion capability and now with the addition of coating and drying capabilities for liquid-based formulations, our clients have access to a complete array of viable and scalable film-manufacturing technologies.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics